The trends are clear: patients and institutions across the nation are concerned about skyrocketing drug prices. This post offers some information about drug pricing, explores the notion of market intervention, and proposes a series of responses to high
Read More...
Read the complete post at http://healthaffairs.org/blog/2015/08/31/rising-cost-of-drugs-where-do-we-go-from-here/
Posted
Aug 31 2015, 09:44 AM
by
Health Affairs Blog
Filed under: Public Health, Featured, Payment Policy, Costs and Spending, Medicaid and CHIP, Drugs and Medical Technology, FDA, hepatitis C, CMS, Big Pharma, Gilead Sciences, Pricewaterhouse Coopers